Here’s what you need to know:
1. The global hip and knee orthopedic surgical robots market, which was valued at $83 million in 2015, is expected to reach $4.5 billion by 2022.
2. This growth is driven by new robotic devices and systems along with a rising geriatric population, which is increasing demand for joint surgeries, particularly noteworthy in the United States.
3. A key barrier to growth is decreasing insurance payments, which encourages hospitals to cut costs.
4. Major market players include Stryker, Smith & Nephew and Johnson & Johnson.
More articles on orthopedics:
Orthopedic procedures see up to 43% direct cost savings in ASC setting: 3 study insights
How are TJR patients in US & Switzerland different? 5 study insights
AAOS receives continuing medical education accreditation with commendation: 3 takeaways
